Infectious Risks and Complications in Adult Leukemic Patients Receiving Blinatumomab.

about

Infectious Risks and Complications in Adult Leukemic Patients Receiving Blinatumomab.

Item

http://www.wikidata.org/entity/Q54213132

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Infectious Risks and Complications in Adult Leukemic Patients Receiving Blinatumomab.

@en

Infectious Risks and Complications in Adult Leukemic Patients Receiving Blinatumomab.

@nl

type

Item

label

Infectious Risks and Complications in Adult Leukemic Patients Receiving Blinatumomab.

@en

Infectious Risks and Complications in Adult Leukemic Patients Receiving Blinatumomab.

@nl

prefLabel

Infectious Risks and Complications in Adult Leukemic Patients Receiving Blinatumomab.

@en

Infectious Risks and Complications in Adult Leukemic Patients Receiving Blinatumomab.

@nl

P1476

Infectious Risks and Complications in Adult Leukemic Patients Receiving Blinatumomab.

@en

P2093

Bijal Shah

http://www.w3.org/2001/XMLSchema#string

John N Greene

http://www.w3.org/2001/XMLSchema#string

Rod Quilitz

http://www.w3.org/2001/XMLSchema#string

Shuchi Pandya

http://www.w3.org/2001/XMLSchema#string

Wonhee So

http://www.w3.org/2001/XMLSchema#string

P2860

Population-based analysis of invasive fungal infections, France, 2001-2010.

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.

The radiological spectrum of pulmonary aspergillosis.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012.

Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis.

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.

Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China.

Incidence, risk factors and outcome of pre engraftment Gram-negative bacteremia after allogeneic and autologous hematopoietic stem cell transplantation: an Italian prospective multicenter survey.

P304

e2018029

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4084/MJHID.2018.029

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29755706

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

5937972

http://www.w3.org/2001/XMLSchema#string